Standout Papers

Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate... 2008 2026 2014 2020 1.2k
  1. Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate (2008)
    Gail D. Lewis Phillips, Guangmin Li et al. Cancer Research

Immediate Impact

8 by Nobel laureates 32 from Science/Nature 85 standout
Sub-graph 1 of 20

Citing Papers

Natural killer cell therapies
2024 StandoutNature
Cancer therapy with antibodies
2024 Standout
10 intermediate papers

Works of Lisa Crocker being referenced

Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate
2008 Standout
A Central Role for HER3 in HER2 -Amplified Breast Cancer: Implications for Targeted Therapy
2008
and 3 more

Author Peers

Author Last Decade Papers Cites
Lisa Crocker 2034 941 1582 24 2.6k
Kathryn L. Parsons 2083 941 1798 11 2.7k
Tomoyuki Kawamoto 1642 1502 1001 26 2.9k
Teemu T. Junttila 2396 1560 1622 32 3.6k
Elaine Mai 1671 794 1495 20 2.3k
Stanford J. Stewart 2481 863 1473 14 3.4k
Wenle Xia 1887 1299 860 30 2.8k
Michael W. Lu 2763 659 1541 18 3.5k
Steven R. Olsen 3008 906 1372 23 3.9k
Serengulam V. Govindan 2237 891 1807 79 3.4k
John Gutheil 2262 1098 1215 38 4.1k

All Works

Loading papers...

Rankless by CCL
2026